Press Release TFII Deadline: Rosen Law Firm Urges TFI International Inc. (NYSE: TFII) Stockholders to Contact the Firm for Information About Their Rights 27 April 2025
Press Release RKLB Deadline: Rosen Law Firm Urges Rocket Lab USA, Inc. (NASDAQ: RKLB) Stockholders to Contact the Firm for Information About Their Rights 27 April 2025
Press Release ELF Deadline: Rosen Law Firm Urges e.l.f. Beauty, Inc. (NYSE: ELF) Stockholders to Contact the Firm for Information About Their Rights 27 April 2025
Press Release QUBT Deadline: Rosen Law Firm Urges Quantum Computing Inc. (NASDAQ: QUBT) Stockholders to Contact the Firm for Information About Their Rights 27 April 2025
Press Release Innorna Announces FDA Rare Pediatric Disease and Orphan Drug Designations Granted to IN013 for Treatment of Wilson Disease 27 April 2025
Press Release EyeMD EMR Healthcare Systems, Inc., a Leading Healthcare Technology Provider for Ophthalmologists, Announces Significant Growth Investment from Performant Capital 26 April 2025
Press Release UroGen Announces Updated 18-Month Duration of Response (DOR) of 80.6% from the Phase 3 ENVISION Trial of UGN-102, an Investigational Treatment for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer (LG-IR-NMIBC) 26 April 2025
Press Release Pfizer’s Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer 26 April 2025
Press Release NSSC Investors Have Opportunity to Lead Napco Security Technologies, Inc. Securities Fraud Lawsuit with the Schall Law Firm 26 April 2025
Press Release UroGen Pharma Announces Encouraging Results from a Phase 1 Dose-Escalation Study Evaluating UGN-301 in Non-Muscle Invasive Bladder Cancer 26 April 2025
